Cargando…
Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy
INTRODUCTION: Among high tuberculosis (TB) and HIV burden countries in Asia, tuberculosis preventive therapy (TPT) in people living with HIV (PLWH) has been underutilized despite its proven benefits independent of antiretroviral therapy (ART). Therefore, we determined the incidence of active TB and...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982319/ https://www.ncbi.nlm.nih.gov/pubmed/35384317 http://dx.doi.org/10.1002/jia2.25900 |
_version_ | 1784681783907844096 |
---|---|
author | Suwanpimolkul, Gompol Gatechompol, Sivaporn Kawkitinarong, Kamon Ueaphongsukkit, Thornthun Sophonphan, Jiratchaya Siriyakorn, Nirada Jirajariyavej, Supunnee Khusuwan, Suwimon Panarat, Palakorn Wannalerdsakun, Surat Saetiew, Natcha Chayangsu, Sunee Wiwatrojanagul, Sirichai Noopetch, Preudtipong Danpornprasert, Praniti Mekviwattanawong, Sripetcharat Fujitnirun, Chris Lertpiriyasuwat, Cheewanan Han, Win Min Kerr, Stephen J. Ruxrungtham, Kiat Avihingsanon, Anchalee |
author_facet | Suwanpimolkul, Gompol Gatechompol, Sivaporn Kawkitinarong, Kamon Ueaphongsukkit, Thornthun Sophonphan, Jiratchaya Siriyakorn, Nirada Jirajariyavej, Supunnee Khusuwan, Suwimon Panarat, Palakorn Wannalerdsakun, Surat Saetiew, Natcha Chayangsu, Sunee Wiwatrojanagul, Sirichai Noopetch, Preudtipong Danpornprasert, Praniti Mekviwattanawong, Sripetcharat Fujitnirun, Chris Lertpiriyasuwat, Cheewanan Han, Win Min Kerr, Stephen J. Ruxrungtham, Kiat Avihingsanon, Anchalee |
author_sort | Suwanpimolkul, Gompol |
collection | PubMed |
description | INTRODUCTION: Among high tuberculosis (TB) and HIV burden countries in Asia, tuberculosis preventive therapy (TPT) in people living with HIV (PLWH) has been underutilized despite its proven benefits independent of antiretroviral therapy (ART). Therefore, we determined the incidence of active TB and mortality among 9179 adult PLWH who attended and received ART from 15 tertiary care hospitals across Thailand. METHODS: A retrospective study was conducted in 2018 using follow‐up data from 1999 to 2018. The primary endpoint was incident TB disease after ART initiation. Factors associated with TB incidence were analysed using competing risk regression. The Kaplan–Meier method was used to estimate mortality after ART initiation. RESULTS: During a median of 5.1 years of ART (IQR 2.2–9.5 years), 442 (4.8%) PLWH developed TB (TB/HIV), giving an overall incidence of 750 (95% CI 683–823) per 100,000 persons‐year of follow up (PYFU). In multivariate analysis, lower CD4 at ART initiation (≤100 cells/mm(3), adjusted sub‐distribution hazard ratio [aSHR]: 2.08, 95% CI, 1.47–2.92; 101–200 cells/mm(3), aSHR: 2.21, 95% CI, 1.54–3.16; 201–350 cells/mm(3), aSHR: 1.59, 95% CI, 1.11–2.28 vs. >350 cells/mm(3)), male sex (aSHR: 1.40, 95% CI, 1.11–1.78), lower body weight (<50 kg, aSHR: 1.52, 95% CI, 1.17–1.95) and prior TB event (aSHR: 3.50, 95% CI, 2.72–4.52) were associated with TB incidence. PLWH with HIV RNA ≥50 copies/ml had 5–9 times higher risk of active TB disease higher than those with HIV RNA <50 copies/ml at the same CD4 level. The risk for developing TB was remarkably high during the initial period of ART (175,511 per 100,000 PYFU at<3 months) and was comparable to the general population after 10 years of ART (151 per 100,000 PYFU). TB/HIV had higher mortality (10% vs. 5%) and poorer HIV treatment outcomes: HIV RNA <50 copies/ml (63.8% vs. 82.8%), CD4 cells count (317 vs. 508 cells/mm(3)) at the most recent visit. CONCLUSIONS: In this high TB burden country, TB incidence was remarkably high during the first few years after ART initiation and thereafter decreased significantly. Rapid ART initiation and appropriate TPT can be potential key interventions to tackle the TB epidemic and reduce mortality among PLWH in TB/HIV high burden settings. |
format | Online Article Text |
id | pubmed-8982319 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89823192022-04-11 Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy Suwanpimolkul, Gompol Gatechompol, Sivaporn Kawkitinarong, Kamon Ueaphongsukkit, Thornthun Sophonphan, Jiratchaya Siriyakorn, Nirada Jirajariyavej, Supunnee Khusuwan, Suwimon Panarat, Palakorn Wannalerdsakun, Surat Saetiew, Natcha Chayangsu, Sunee Wiwatrojanagul, Sirichai Noopetch, Preudtipong Danpornprasert, Praniti Mekviwattanawong, Sripetcharat Fujitnirun, Chris Lertpiriyasuwat, Cheewanan Han, Win Min Kerr, Stephen J. Ruxrungtham, Kiat Avihingsanon, Anchalee J Int AIDS Soc Research Articles INTRODUCTION: Among high tuberculosis (TB) and HIV burden countries in Asia, tuberculosis preventive therapy (TPT) in people living with HIV (PLWH) has been underutilized despite its proven benefits independent of antiretroviral therapy (ART). Therefore, we determined the incidence of active TB and mortality among 9179 adult PLWH who attended and received ART from 15 tertiary care hospitals across Thailand. METHODS: A retrospective study was conducted in 2018 using follow‐up data from 1999 to 2018. The primary endpoint was incident TB disease after ART initiation. Factors associated with TB incidence were analysed using competing risk regression. The Kaplan–Meier method was used to estimate mortality after ART initiation. RESULTS: During a median of 5.1 years of ART (IQR 2.2–9.5 years), 442 (4.8%) PLWH developed TB (TB/HIV), giving an overall incidence of 750 (95% CI 683–823) per 100,000 persons‐year of follow up (PYFU). In multivariate analysis, lower CD4 at ART initiation (≤100 cells/mm(3), adjusted sub‐distribution hazard ratio [aSHR]: 2.08, 95% CI, 1.47–2.92; 101–200 cells/mm(3), aSHR: 2.21, 95% CI, 1.54–3.16; 201–350 cells/mm(3), aSHR: 1.59, 95% CI, 1.11–2.28 vs. >350 cells/mm(3)), male sex (aSHR: 1.40, 95% CI, 1.11–1.78), lower body weight (<50 kg, aSHR: 1.52, 95% CI, 1.17–1.95) and prior TB event (aSHR: 3.50, 95% CI, 2.72–4.52) were associated with TB incidence. PLWH with HIV RNA ≥50 copies/ml had 5–9 times higher risk of active TB disease higher than those with HIV RNA <50 copies/ml at the same CD4 level. The risk for developing TB was remarkably high during the initial period of ART (175,511 per 100,000 PYFU at<3 months) and was comparable to the general population after 10 years of ART (151 per 100,000 PYFU). TB/HIV had higher mortality (10% vs. 5%) and poorer HIV treatment outcomes: HIV RNA <50 copies/ml (63.8% vs. 82.8%), CD4 cells count (317 vs. 508 cells/mm(3)) at the most recent visit. CONCLUSIONS: In this high TB burden country, TB incidence was remarkably high during the first few years after ART initiation and thereafter decreased significantly. Rapid ART initiation and appropriate TPT can be potential key interventions to tackle the TB epidemic and reduce mortality among PLWH in TB/HIV high burden settings. John Wiley and Sons Inc. 2022-04-05 /pmc/articles/PMC8982319/ /pubmed/35384317 http://dx.doi.org/10.1002/jia2.25900 Text en © 2022 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Suwanpimolkul, Gompol Gatechompol, Sivaporn Kawkitinarong, Kamon Ueaphongsukkit, Thornthun Sophonphan, Jiratchaya Siriyakorn, Nirada Jirajariyavej, Supunnee Khusuwan, Suwimon Panarat, Palakorn Wannalerdsakun, Surat Saetiew, Natcha Chayangsu, Sunee Wiwatrojanagul, Sirichai Noopetch, Preudtipong Danpornprasert, Praniti Mekviwattanawong, Sripetcharat Fujitnirun, Chris Lertpiriyasuwat, Cheewanan Han, Win Min Kerr, Stephen J. Ruxrungtham, Kiat Avihingsanon, Anchalee Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy |
title | Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy |
title_full | Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy |
title_fullStr | Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy |
title_full_unstemmed | Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy |
title_short | Incidence of active tuberculosis among people living with HIV receiving long‐term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy |
title_sort | incidence of active tuberculosis among people living with hiv receiving long‐term antiretroviral therapy in high tb/hiv burden settings in thailand: implication for tuberculosis preventive therapy |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982319/ https://www.ncbi.nlm.nih.gov/pubmed/35384317 http://dx.doi.org/10.1002/jia2.25900 |
work_keys_str_mv | AT suwanpimolkulgompol incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT gatechompolsivaporn incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT kawkitinarongkamon incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT ueaphongsukkitthornthun incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT sophonphanjiratchaya incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT siriyakornnirada incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT jirajariyavejsupunnee incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT khusuwansuwimon incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT panaratpalakorn incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT wannalerdsakunsurat incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT saetiewnatcha incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT chayangsusunee incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT wiwatrojanagulsirichai incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT noopetchpreudtipong incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT danpornprasertpraniti incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT mekviwattanawongsripetcharat incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT fujitnirunchris incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT lertpiriyasuwatcheewanan incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT hanwinmin incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT kerrstephenj incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT ruxrungthamkiat incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT avihingsanonanchalee incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy AT incidenceofactivetuberculosisamongpeoplelivingwithhivreceivinglongtermantiretroviraltherapyinhightbhivburdensettingsinthailandimplicationfortuberculosispreventivetherapy |